BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 27629910)

  • 1. Stabilization of circulating thyroglobulin mRNA transcripts in patients treated for differentiated thyroid carcinoma.
    Feddersen S; Bastholt L; Pedersen SM
    Ann Clin Biochem; 2017 Sep; 54(5):558-566. PubMed ID: 27629910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preanalytical robustness of blood collection tubes with RNA stabilizers.
    Stellino C; Hamot G; Bellora C; Trouet J; Betsou F
    Clin Chem Lab Med; 2019 Sep; 57(10):1522-1529. PubMed ID: 31112504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-time quantitative PCR measurement of thyroglobulin mRNA in peripheral blood of thyroid cancer patients and healthy subjects.
    Li D; Butt A; Clarke S; Swaminathana R
    Ann N Y Acad Sci; 2004 Jun; 1022():147-51. PubMed ID: 15251954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroglobulin mRNA quantification in the peripheral blood is not a reliable marker for the follow-up of patients with differentiated thyroid cancer.
    Eszlinger M; Neumann S; Otto L; Paschke R
    Eur J Endocrinol; 2002 Nov; 147(5):575-82. PubMed ID: 12444888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression differences between PAXgene and Tempus blood RNA tubes are highly reproducible between independent samples and biobanks.
    Skogholt AH; Ryeng E; Erlandsen SE; Skorpen F; Schønberg SA; Sætrom P
    BMC Res Notes; 2017 Mar; 10(1):136. PubMed ID: 28335817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular diagnosis of residual and recurrent thyroid cancer by amplification of thyroglobulin messenger ribonucleic acid in peripheral blood.
    Ringel MD; Ladenson PW; Levine MA
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4435-42. PubMed ID: 9851791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative reverse transcription-polymerase chain reaction of circulating thyroglobulin messenger ribonucleic acid for monitoring patients with thyroid carcinoma.
    Ringel MD; Balducci-Silano PL; Anderson JS; Spencer CA; Silverman J; Sparling YH; Francis GL; Burman KD; Wartofsky L; Ladenson PW; Levine MA; Tuttle RM
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4037-42. PubMed ID: 10566646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real time RT-PCR analysis of thyroglobulin mRNA in peripheral blood in patients with congenital athyreosis and with differentiated thyroid carcinoma after stimulation with recombinant human thyrotropin.
    Kaufmann S; Schmutzler C; Schomburg L; Körber C; Luster M; Rendl J; Reiners C; Köhrle J
    Endocr Regul; 2004 Jun; 38(2):41-9. PubMed ID: 15497927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of quantitative measurement of thyroglobulin mRNA in the follow-up of differentiated thyroid cancer.
    Denizot A; Delfino C; Dutour-Meyer A; Fina F; Ouafik L
    Thyroid; 2003 Sep; 13(9):867-72. PubMed ID: 14588101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood thyroglobulin and TSH receptor mRNA detection by RT-PCR in the follow-up of differentiated thyroid cancer patients.
    Torosian L; Manrique G; Alvarez B; Lago G; Roca R; Belzarena C
    Rev Esp Med Nucl; 2010; 29(3):109-13. PubMed ID: 20399540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stabilization of mRNA expression in whole blood samples.
    Rainen L; Oelmueller U; Jurgensen S; Wyrich R; Ballas C; Schram J; Herdman C; Bankaitis-Davis D; Nicholls N; Trollinger D; Tryon V
    Clin Chem; 2002 Nov; 48(11):1883-90. PubMed ID: 12406972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a sensitive and specific quantitative reverse transcription-polymerase chain reaction assay for blood thyroglobulin messenger ribonucleic acid in the follow-up of patients with differentiated thyroid carcinoma.
    Boldarine VT; Maciel RM; Guimarães GS; Nakabashi CC; Camacho CP; Andreoni DM; Mamone Mda C; Ikejiri ES; Kasamatsu TS; Crispim F; Hojaij FC; Hidal JT; Biscolla RP
    J Clin Endocrinol Metab; 2010 Apr; 95(4):1726-33. PubMed ID: 20173019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative measurement of thyroglobulin mRNA in peripheral blood of patients after total thyroidectomy.
    Takano T; Miyauchi A; Yoshida H; Hasegawa Y; Kuma K; Amino N
    Br J Cancer; 2001 Jul; 85(1):102-6. PubMed ID: 11437410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Streck BCT and PAXgene Stabilised Blood Collection Tubes for Cell-Free Circulating DNA Studies in Plasma.
    Warton K; Yuwono NL; Cowley MJ; McCabe MJ; So A; Ford CE
    Mol Diagn Ther; 2017 Oct; 21(5):563-570. PubMed ID: 28631163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low specificity of blood thyroglobulin messenger ribonucleic acid assay prevents its use in the follow-up of differentiated thyroid cancer patients.
    Elisei R; Vivaldi A; Agate L; Molinaro E; Nencetti C; Grasso L; Pinchera A; Pacini F
    J Clin Endocrinol Metab; 2004 Jan; 89(1):33-9. PubMed ID: 14715824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly sensitive serum thyroglobulin and circulating thyroglobulin mRNA evaluations in the management of patients with differentiated thyroid cancer in apparent remission.
    Fugazzola L; Mihalich A; Persani L; Cerutti N; Reina M; Bonomi M; Ponti E; Mannavola D; Giammona E; Vannucchi G; di Blasio AM; Beck-Peccoz P
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3201-8. PubMed ID: 12107225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood presence of circulating oncofetal fibronectin mRNA, by RT-PCR, does not represent a useful specific marker for the management and follow-up of thyroid cancer patients.
    Vendittelli F; Raffaelli M; Fadda G; Carelli-Alinovi C; Paolillo C; Bellantone R; Zuppi C; Capoluongo E
    Clin Chem Lab Med; 2012 Jan; 50(4):715-20. PubMed ID: 22505562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of whole blood RNA preservation tubes and novel generation RNA extraction kits for analysis of mRNA and MiRNA profiles.
    Häntzsch M; Tolios A; Beutner F; Nagel D; Thiery J; Teupser D; Holdt LM
    PLoS One; 2014; 9(12):e113298. PubMed ID: 25469788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examination of stability of bone marrow blood RNA in the PAXgene tube.
    Yamamoto T; Sekiyama A; Sekiguchi H; Yoshida T; Miyagi Y
    Lab Hematol; 2006; 12(3):143-7. PubMed ID: 16950675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preanalytical aspects of quantitative TaqMan real-time RT-PCR: applications for TF and VEGF mRNA quantification.
    Isaksson HS; Nilsson TK
    Clin Biochem; 2006 Apr; 39(4):373-7. PubMed ID: 16546153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.